CD164 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD164 monoclonal antibodies for research focused on understanding this important protein. CD164 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD164, also known as the hematopoietic stem cell antigen, plays a crucial role in cell adhesion and migration, influencing processes such as hematopoiesis and immune response. CD164 expression is particularly significant in stem cell biology and cancer research, making CD164 monoclonal antibodies essential for advancing these fields. Researchers can utilize CD164 monoclonal antibodies to investigate cellular pathways and molecular mechanisms in both normal and disease states. Advanced research techniques incorporating CD164 monoclonal antibodies enable detailed analysis of protein interactions and cellular signaling networks. Understanding CD164's role in various biological processes can lead to new insights in therapeutic development. Santa Cruz Biotechnology monoclonal antibodies for CD164 continue to support breakthrough discoveries in the scientific community, advancing our understanding of cellular processes and disease mechanisms.